VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/41912491/

⇱ Brain network localization of anhedonia - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

Anhedonia, encompassing a broad spectrum of deficits in reward processing, is highly prevalent in major depressive disorder (MDD) and constitutes one of its core symptoms. While substantial progress has recently been made in mapping neuropsychiatric symptoms to specific brain networks, focused efforts to examine network localization of anhedonia are limited. We initially synthesized extant neuroimaging literature to identify brain locations with structural or functional alterations related to anhedonia. By integrating these affected brain locations with large-scale discovery (1113 healthy individuals) and validation (1093 healthy individuals and 255 MDD patients) resting-state functional magnetic resonance imaging datasets, we then applied novel functional connectivity network mapping to construct an anhedonia network. The anhedonia network was composed of the dorsal anterior cingulate cortex, insula, lateral prefrontal cortex, and striatum, principally implicating the canonical ventral attention and subcortical networks. Further analyses revealed that the trait and state anhedonia networks preferentially involved the default and limbic networks respectively, in addition to the commonly affected ventral attention and subcortical networks. Our findings may not only advance the understanding of the neurobiology underlying anhedonia from a network perspective, but also potentially contribute to more targeted and effective intervention strategies for anhedonia.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: The original studies providing the HCP, AMUD, and MDD datasets received ethical approval from the relevant Institutional Review Boards (IRBs) or ethics committees. Specifically, the HCP study was approved by the Institutional Review Board of Washington University in St. Louis, MO, USA, and written informed consent was obtained from each participant. All participants in the AMUD and MDD datasets provided informed consent under protocols approved by The First Affiliated Hospital of Anhui Medical University. The datasets utilized in this study were anonymized to ensure participant confidentiality, containing no protected health information or personally identifiable images. All procedures involving human participants were performed in accordance with the relevant guidelines and regulations, in compliance with the ethical principles of the Declaration of Helsinki and its later amendments or comparable standards.

Figures

👁 Fig. 1
Fig. 1. Study procedure and data analysis.
We initially synthesized extant neuroimaging literature to identify brain locations with structural or functional alterations related to anhedonia. By integrating these affected brain locations with large-scale discovery (AMUD) and validation (HCP and MDD) resting-state fMRI datasets, we then applied the FCNM approach to construct an anhedonia network. Specifically, spheres centered at each coordinate of a contrast were first created and merged together to generate a contrast-specific combined seed mask. Second, based on the resting-state BOLD fMRI data, we computed a contrast seed-to-whole brain rsFC map for each subject. Third, the subject-level rsFC maps were entered into a voxel-wise one-sample t test to identify brain regions functionally connected to each contrast seed. Fourth, the resulting group-level t maps were thresholded and binarized. Finally, the binarized maps were overlaid to produce a network probability map, which was thresholded at 50% to yield the anhedonia network. AMUD Anhui Medical University Dataset, BOLD blood-oxygen-level-dependent, FCNM functional connectivity network mapping, fMRI functional magnetic resonance imaging, HCP Human Connectome Project, MDD major depressive disorder, rsFC resting-state functional connectivity.
👁 Fig. 2
Fig. 2. Anhedonia network and its association with canonical brain networks.
A The anhedonia network is shown as the network probability map thresholded at 50%, indicating brain regions functionally connected to more than 50% of the contrast seeds. B Polar plot displays the proportion of overlapping voxels between the anhedonia network and a canonical network to all voxels within the corresponding canonical network. L left, R right.
👁 Fig. 3
Fig. 3. Trait and state anhedonia networks and their associations with canonical brain networks.
A Trait anhedonia network and its association with canonical brain networks. B State anhedonia network and its association with canonical brain networks. The trait and state anhedonia networks are shown as the network probability maps thresholded at 50%, indicating brain regions functionally connected to more than 50% of the contrast seeds. Polar plots display the proportion of overlapping voxels between the trait and state anhedonia networks and a canonical network to all voxels within the corresponding canonical network. L left, R right.

References

    1. Rizvi SJ, Pizzagalli DA, Sproule BA, Kennedy SH. Assessing anhedonia in depression: potentials and pitfalls. Neurosci Biobehav Rev. 2016;65:21–35. - DOI - PMC - PubMed
    1. Rizvi SJ, Lambert C, Kennedy S. Presentation and neurobiology of anhedonia in mood disorders: commonalities and distinctions. Curr Psychiatry Rep. 2018;20:13. - DOI - PubMed
    1. Serretti A. Anhedonia and depressive disorders. Clin Psychopharmacol Neurosci. 2023;21:401–9. - DOI - PMC - PubMed
    1. Wang S, Leri F, Rizvi SJ. Anhedonia as a central factor in depression: neural mechanisms revealed from preclinical to clinical evidence. Prog Neuropsychopharmacol Biol Psychiatry. 2021;110:110289. - DOI - PubMed
    1. Ducasse D, Loas G, Dassa D, Gramaglia C, Zeppegno P, Guillaume S, et al. Anhedonia is associated with suicidal ideation independently of depression: a meta-analysis. Depress Anxiety. 2018;35:382–92. - DOI - PubMed

LinkOut - more resources

Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.